TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19723429

Group type: EXPERIMENTAL
Intervention: Brushing for 180 seconds with 1.5 g Aquafresh Advanced dentifrice
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Brushing for 120 seconds with 1.5 g Aquafresh Advanced dentifrice
Number of subjects: 47

Group type: COMPARATOR
Intervention: Brushing for 60 seconds without dentifrice
Number of subjects: 47
Study: 18451231

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Letrozole with cyclophosphamide
Number of subjects: 113
Study: 16124664

Group type: EXPERIMENTAL
Intervention: Radiofrequency surgery of the soft palate (2 sessions, total energy: 3,300 Joule)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (insertion of device needle without energy delivery)
Number of subjects: 26
Study: 12153962

Group type: EXPERIMENTAL
Intervention: HDM allergen-impermeable mattress covers
Number of subjects: 1282

Group type: COMPARATOR
Intervention: Placebo covers
Number of subjects: 1282

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 1282
Study: 9892228

Group type: COMPARATOR
Intervention: Human regular insulin (0.075 U/kg lean body mass)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Insulin analog lispro (0.075 U/kg lean body mass)
Number of subjects: 8
Study: 8851775

Group type: EXPERIMENTAL
Intervention: Videotape segments of real-world scenes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Still photographs of real-world scenes
Number of subjects: 0
Study: 2180458

Group type: EXPERIMENTAL
Intervention: Capitation system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fee-for-service system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both systems
Number of subjects: 0
Study: 6767404

Group type: EXPERIMENTAL
Intervention: Mestranol 50 micrograms and norethindrone 1 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol 50 micrograms and norethindrone 1 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol 35 micrograms and norethindrone 1 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol 30 micrograms and levonorgestrel 150 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Contraceptive vaginal ring (CVR) containing levonorgestrel and estradiol
Number of subjects: 100
Study: 30199738

Group type: EXPERIMENTAL
Intervention: Memory Flexibility (MemFlex) training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Psychoeducation (Control)
Number of subjects: 60
Study: 25810426

Group type: EXPERIMENTAL
Intervention: Discordant participants with high perceived balance and low measured balance
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Discordant participants with low perceived balance and high measured balance
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Concordant participants with high perceived and measured balance
Number of subjects: 352
Study: 24926949

Group type: EXPERIMENTAL
Intervention: 400 IU of oral vitamin D2 daily (Arm A)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 1000 IU daily in summer/fall and 2000 IU in winter/spring (Arm B)
Number of subjects: 63
Study: 23441533

Group type: EXPERIMENTAL
Intervention: Erythropoietin treatment
Number of subjects: 62

Group type: COMPARATOR
Intervention: Other treatments for renal anemia
Number of subjects: 62
Study: 20212395

Group type: EXPERIMENTAL
Intervention: Nebulized L‐epinephrine (LE)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone dipropionate (BD) 200 mg
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Intramuscular dexamethasone (D) 0.6 mg/kg
Number of subjects: 64
Study: 18411237

Group type: EXPERIMENTAL
Intervention: Low-dose naloxone infusion (0.25 microg/kg per hour)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 82
Study: 16364244

Group type: EXPERIMENTAL
Intervention: ND4 G11696A mutation
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: N405D in the ND5 and G5820A in the tRNA(Cys)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Absence of functionally significant mtDNA mutations
Number of subjects: 5
Study: 12552209

Group type: EXPERIMENTAL
Intervention: 1% hyperbaric lidocaine
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: 5% hyperbaric lidocaine
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: TNS present
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: TNS absent
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: TNS patients
Number of subjects: 453
Study: 10591360

Group type: EXPERIMENTAL
Intervention: ramosetron 0.3 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: granisetron 3 mg
Number of subjects: 100
Study: 9360939

Group type: EXPERIMENTAL
Intervention: Bacterial lysate treatment for three months
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group (N=10)
Number of subjects: 11
Study: 1942929

Group type: EXPERIMENTAL
Intervention: Intraarterial administration of cisplatinum
Number of subjects: 118

Group type: COMPARATOR
Intervention: Intravenous administration of cisplatinum
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Overall response rate for all patients
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Overall metastasis free survival (MFS)
Number of subjects: 118
Study: 7461024

Group type: EXPERIMENTAL
Intervention: 0.25 mg oral digoxin
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 0.5 mg oral digoxin
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 1.0 mg oral digoxin
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 1.5 mg oral digoxin
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 2.0 mg oral digoxin
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: All doses
Number of subjects: 9
Study: 31317459

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (LAP)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Open surgery (OPEN)
Number of subjects: 256
Study: 30962499

Group type: EXPERIMENTAL
Intervention: Dietary magnesium intake
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) level
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: Interleukin-6 (IL-6)
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: Path analysis of dietary magnesium
Number of subjects: 1050
Study: 27837273

Group type: EXPERIMENTAL
Intervention: ONSTEP technique
Number of subjects: 290

Group type: COMPARATOR
Intervention: Lichtenstein technique
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 290
Study: 25532675

Group type: EXPERIMENTAL
Intervention: Vegan diet
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Vegetarian diet
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Pescovegetarian diet
Number of subjects: 61

Group type: COMPARATOR
Intervention: Semivegetarian diet
Number of subjects: 61

Group type: COMPARATOR
Intervention: Omnivorous diet
Number of subjects: 61
Study: 23652826

Group type: EXPERIMENTAL
Intervention: Combination therapy (simvastatin 40 mg and ezetimibe 10 mg daily)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Statin monotherapy (simvastatin 40 mg daily)
Number of subjects: 15
Study: 21722832

Group type: EXPERIMENTAL
Intervention: Conventional open surgical repair
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endovascular treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hybrid technique
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Refinements in open surgical techniques and branched endovascular graft repair
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hybrid techniques
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Circumstantial evidence
Number of subjects: 0
Study: 19758522

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 17211442

Group type: EXPERIMENTAL
Intervention: Alfuzosin 10 mg once daily
Number of subjects: 372

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 372
Study: 15135704

Group type: EXPERIMENTAL
Intervention: Eptifibatide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tirofiban HCl
Number of subjects: 0
Study: 11282752

Group type: EXPERIMENTAL
Intervention: ESAT-6-specific IFN-gamma-secreting T cells
Number of subjects: 146

Group type: COMPARATOR
Intervention: Diagnostic tuberculin skin test (TST)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: ESAT-6-specific T cells
Number of subjects: 146

Group type: COMPARATOR
Intervention: Unexposed BCG-vaccinated subjects
Number of subjects: 146
Study: 9644529

Group type: EXPERIMENTAL
Intervention: Cefodizime (modivid) used prophylactically in cholecystectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cefodizime (modivid)
Number of subjects: 0
Study: 7943118

Group type: EXPERIMENTAL
Intervention: Troxerutin
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 3075441

Group type: EXPERIMENTAL
Intervention: Mefloquine-sulphadoxine-pyrimethamine (MSP, Fansimef)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chloroquine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mefloquine
Number of subjects: 0
Study: 31506338

Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 6

Group type: COMPARATOR
Intervention: Lateral decubitus position
Number of subjects: 6
Study: 27736028

Group type: EXPERIMENTAL
Intervention: Intravenous and intracoronary melatonin
Number of subjects: 146
Study: 26557623

Group type: EXPERIMENTAL
Intervention: Various sensory input methods (multisensory approach)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Unisensory method
Number of subjects: 200
Study: 24167976

Group type: EXPERIMENTAL
Intervention: Hochuekkito (TJ‐41) 7.5 g/day for 7 days before surgery
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 48
Study: 21804670

Group type: EXPERIMENTAL
Intervention: A‐Flex
Number of subjects: 168

Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 168

Group type: COMPARATOR
Intervention: APAP (switched to CPAP at fixed pressure)
Number of subjects: 168
Study: 19394009

Group type: EXPERIMENTAL
Intervention: Autofluorescence imaging
Number of subjects: 0

Group type: COMPARATOR
Intervention: White-light endoscopy
Number of subjects: 0
Study: 19468545

Group type: EXPERIMENTAL
Intervention: ondansetron (4 mg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: metoclopramide (10 mg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: droperidol (1.25 mg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: dexametasone (8 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no medication)
Number of subjects: 100
Study: 15059263

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 11701101

Group type: EXPERIMENTAL
Intervention: Lumbar spine radiography and usual care
Number of subjects: 476

Group type: COMPARATOR
Intervention: Usual care without radiography
Number of subjects: 476
Study: 9466094

Group type: EXPERIMENTAL
Intervention: Propofol (2 mg kg‐1 h‐1)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Midazolam (0.06 mg kg‐1 h‐1)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Gamma-hydroxybutyrate (20 mg kg‐1 h‐1)
Number of subjects: 45
Study: 7955138

Group type: EXPERIMENTAL
Intervention: Behavioural management approach to treating sleeping problems
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 0
Study: 3667022

Group type: EXPERIMENTAL
Intervention: Sucrose (81 +/- 18 g)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Caffeine (384 +/- 13 mg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Sucrose (72 +/- 22 g) plus caffeine (396 +/- 29 mg)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Sucrose plus caffeine
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Sucrose
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control
Number of subjects: 5
Study: 29421772

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (CQ10) supplementation 100 mg/d for 12 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 26694632

Group type: EXPERIMENTAL
Intervention: 2% chamomile gel applied twice daily for 1 month
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo applied twice daily for 1 month
Number of subjects: 62
Study: 24462464

Group type: EXPERIMENTAL
Intervention: Nitroglycerin plus oral vinorelbine plus cisplatin
Number of subjects: 66

Group type: COMPARATOR
Intervention: Oral vinorelbine plus cisplatin alone (placebo)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both groups (Nitroglycerin and Control)
Number of subjects: 66
Study: 23773411

Group type: EXPERIMENTAL
Intervention: RT+CON (radiotherapy with carbogen and nicotinamide)
Number of subjects: 231

Group type: COMPARATOR
Intervention: RT (radiotherapy alone)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: RT+CON versus RT
Number of subjects: 231
Study: 20006908

Group type: EXPERIMENTAL
Intervention: Spectacles plus patching >or=8 hours daily 6 days a week
Number of subjects: 40

Group type: COMPARATOR
Intervention: Spectacles plus patching >or=8 hours on alternate days
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (daily and alternate-day occlusion)
Number of subjects: 40
Study: 19057729

Group type: EXPERIMENTAL
Intervention: Preoperative autologous blood donation (Group B)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (Group A)
Number of subjects: 48
Study: 17086005

Group type: EXPERIMENTAL
Intervention: Stress testing with blinded troponins
Number of subjects: 241

Group type: COMPARATOR
Intervention: Troponin I-guided strategy
Number of subjects: 241
Study: 12954744

Group type: EXPERIMENTAL
Intervention: High-saturation group (target functional oxygen-saturation range of 95 to 98 percent)
Number of subjects: 358

Group type: COMPARATOR
Intervention: Standard-saturation group (target functional oxygen-saturation range of 91 to 94 percent)
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: High-saturation group
Number of subjects: 358

Group type: COMPARATOR
Intervention: Standard-saturation group
Number of subjects: 358
Study: 11532470

Group type: EXPERIMENTAL
Intervention: Microdeletions of the long arm of chromosome Y (AZFa, AZFb, AZFc)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Semen analysis and hormonal measurements (FSH, LH, testosterone, prolactin, estradiol)
Number of subjects: 54
Study: 9489595

Group type: EXPERIMENTAL
Intervention: Morphine delivered over 40 seconds with a 5 min lockout interval
Number of subjects: 40

Group type: COMPARATOR
Intervention: Morphine delivered over 5 minutes with a 1 min lockout interval
Number of subjects: 40
Study: 7827744

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) twice weekly for one hour each session
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (local wound care followed by application of an Unna boot)
Number of subjects: 22
Study: 3413461

Group type: EXPERIMENTAL
Intervention: 20 mg slow-release pindolol once daily
Number of subjects: 12

Group type: COMPARATOR
Intervention: 5 mg pindolol three times daily
Number of subjects: 12
Study: 31701483

Group type: EXPERIMENTAL
Intervention: Dementia Care Mapping™ (DCM)
Number of subjects: 726

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 726
Study: 29297980

Group type: EXPERIMENTAL
Intervention: ledipasvir-sofosbuvir
Number of subjects: 239

Group type: COMPARATOR
Intervention: sofosbuvir + ribavirin
Number of subjects: 239
Study: 28441068

Group type: EXPERIMENTAL
Intervention: C‐NAC eye drops (1 instillation in 1 eye)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: C‐NAC eye drops (QD or BID for 5 days)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (normal saline solution)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: C‐NAC eye drops (both cohorts)
Number of subjects: 38
Study: 26220179

Group type: EXPERIMENTAL
Intervention: Kinesio Tape (KT) applied to quadriceps muscles
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional rehabilitation program
Number of subjects: 24
Study: 23782773

Group type: EXPERIMENTAL
Intervention: Biological mesh
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional wound care
Number of subjects: 100
Study: 20616787

Group type: EXPERIMENTAL
Intervention: Watermelon supplementation (L-citrulline/L-arginine, 2.7 g/1.3 g/day)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 18221288

Group type: EXPERIMENTAL
Intervention: 100 mg udenafil
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: 200 mg udenafil
Number of subjects: 167

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 167
Study: 17212078

Group type: EXPERIMENTAL
Intervention: ART (Atraumatic Restorative Treatment)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Conventional cavity preparation
Number of subjects: 157
Study: 14719760

Group type: EXPERIMENTAL
Intervention: Self-etch adhesive (Clearfil SE Bond)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Total-etch adhesive (Prime & Bond NT)
Number of subjects: 66
Study: 10925662

Group type: EXPERIMENTAL
Intervention: EHF therapy + magnetotherapy + drugs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard drug therapy
Number of subjects: 0
Study: 8930569

Group type: EXPERIMENTAL
Intervention: Lactose-restricted diet for 6 weeks
Number of subjects: 105

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 105
Study: 14621839

Group type: EXPERIMENTAL
Intervention: 3 pulses of 8 mg/kg methylprednisolone (MPS) in an alternate‐day regimen (total dose 25 mg/kg in 1 week)
Number of subjects: 46

Group type: COMPARATOR
Intervention: 5 daily pulses of 3 mg/kg MPS (total dose 17 mg/kg)
Number of subjects: 46
Study: 31820806

Group type: EXPERIMENTAL
Intervention: Nodule excision
Number of subjects: 60

Group type: COMPARATOR
Intervention: Segmental resection
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nodule excision and Segmental resection
Number of subjects: 60
Study: 29898058

Group type: EXPERIMENTAL
Intervention: In-office bleaching with 38% peroxide hydrogen followed by a second in-office session
Number of subjects: 40

Group type: COMPARATOR
Intervention: In-office bleaching with 38% peroxide hydrogen followed by at-home bleaching with 10% carbamide peroxide for 7 days
Number of subjects: 40
Study: 26861445

Group type: EXPERIMENTAL
Intervention: Advergame promoting energy-dense snacks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (no advergame)
Number of subjects: 0
Study: 24454918

Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: RMS ECG
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: LQT-2
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: LQT-1 and LQT-3
Number of subjects: 262

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 262
Study: 22818724

Group type: EXPERIMENTAL
Intervention: Social Cognitive Theory-based counseling paired with technology-based self-monitoring
Number of subjects: 296

Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 296
Study: 20571361

Group type: EXPERIMENTAL
Intervention: Intraoperative hypothermia (33.3 degrees +/- 0.8 degrees C)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Normothermia (36.7 degrees +/- 0.5 degrees C)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Intraoperative hypothermia
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Normothermia
Number of subjects: 1000
Study: 18001429

Group type: EXPERIMENTAL
Intervention: Skin prick test (SPT) with fresh cow's milk
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Skin prick test (SPT) with casein
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Skin prick test (SPT) with all three milk proteins (alpha-lactalbumin, casein, beta-lactoglobulin)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Skin prick test (SPT) with alpha-lactalbumin
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Skin prick test (SPT) with beta-lactoglobulin
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Food challenge test
Number of subjects: 104
Study: 16339333

Group type: EXPERIMENTAL
Intervention: Testosterone replacement
Number of subjects: 1084

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1084
Study: 12000000

Group type: EXPERIMENTAL
Intervention: Easyhaler (budesonide 800 microg day(-1), 200 g dose(-1), two inhalations twice daily for 12 weeks)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Turbuhaler (budesonide 800 microg day(-1), 200 g dose(-1), two inhalations twice daily for 12 weeks)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Easyhaler
Number of subjects: 161

Group type: COMPARATOR
Intervention: Turbuhaler
Number of subjects: 161
Study: 10434872

Group type: EXPERIMENTAL
Intervention: Normal tension glaucoma patients
Number of subjects: 24

Group type: COMPARATOR
Intervention: Age matched controls
Number of subjects: 24
Study: 7763063

Group type: EXPERIMENTAL
Intervention: Budesonide (400 micrograms/day)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 2271378

Group type: EXPERIMENTAL
Intervention: Frusemide 40 mg (F)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Frusemide 40 mg in combination with triamterene 50 mg (F+T)
Number of subjects: 12
Study: 6986552

Group type: EXPERIMENTAL
Intervention: Leboyer method of delivery
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional delivery
Number of subjects: 56
Study: 29723066

Group type: EXPERIMENTAL
Intervention: Web-based patient education (WBPE) with action and coping plans
Number of subjects: 108

Group type: COMPARATOR
Intervention: Attention-control group (web-based neutral information program about shoulder injuries)
Number of subjects: 108
Study: 28282219

Group type: EXPERIMENTAL
Intervention: IDegLira
Number of subjects: 2
Study: 25832102

Group type: EXPERIMENTAL
Intervention: Single MenC-CRM dose at 3 months
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Two doses of MenC-CRM at 3 and 4 months
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Single MenC-polysaccharide-TT dose at 3 months
Number of subjects: 509

Group type: COMPARATOR
Intervention: No MenC doses
Number of subjects: 509
Study: 22457418

Group type: EXPERIMENTAL
Intervention: Lipid emulsion (LPD) group received 100 mL of a 20% soybean oil emulsion for 7 days after esophagectomy.
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group received parenteral feeding with a glucose-based solution only.
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Lipid emulsion (LPD) group
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32